27.80
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$28.38
Aprire:
$28.29
Volume 24 ore:
5.15M
Relative Volume:
1.05
Capitalizzazione di mercato:
$14.26B
Reddito:
$17.28B
Utile/perdita netta:
$108.00M
Rapporto P/E:
139.00
EPS:
0.2
Flusso di cassa netto:
$391.00M
1 W Prestazione:
-0.61%
1M Prestazione:
-19.63%
6M Prestazione:
-24.15%
1 anno Prestazione:
-30.57%
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(847) 948-2000
Indirizzo
ONE BAXTER PKWY, DEERFIELD, IL
Confronta BAX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
BAX
Baxter International Inc
|
27.80 | 14.26B | 17.28B | 108.00M | 391.00M | 0.20 |
![]()
ISRG
Intuitive Surgical Inc
|
488.27 | 174.93B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
202.04 | 58.01B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
91.42 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
213.97 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
77.80 | 15.49B | 3.90B | 392.30M | 288.10M | 1.95 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-02-26 | Ripresa | Goldman | Buy |
2025-02-24 | Aggiornamento | Argus | Hold → Buy |
2025-02-20 | Ripresa | Barclays | Overweight |
2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2024-05-30 | Iniziato | Goldman | Neutral |
2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
2023-03-29 | Iniziato | UBS | Neutral |
2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
2022-10-18 | Iniziato | Barclays | Overweight |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-04-04 | Downgrade | Goldman | Neutral → Sell |
2022-03-02 | Ripresa | BofA Securities | Buy |
2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
2022-02-18 | Reiterato | Morgan Stanley | Overweight |
2022-02-18 | Reiterato | Raymond James | Outperform |
2022-02-18 | Reiterato | Stifel | Buy |
2022-02-18 | Reiterato | UBS | Neutral |
2022-02-18 | Reiterato | Wells Fargo | Overweight |
2022-02-11 | Iniziato | Goldman | Neutral |
2022-01-07 | Ripresa | Citigroup | Buy |
2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
2021-05-25 | Iniziato | Barclays | Equal Weight |
2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
2021-01-06 | Downgrade | UBS | Buy → Neutral |
2020-12-15 | Downgrade | Goldman | Buy → Neutral |
2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
2020-09-04 | Downgrade | Argus | Buy → Hold |
2020-06-24 | Iniziato | Oppenheimer | Outperform |
2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-05 | Iniziato | Citigroup | Neutral |
2020-02-13 | Iniziato | Goldman | Buy |
2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
2018-11-02 | Aggiornamento | Argus | Hold → Buy |
2018-10-16 | Iniziato | Barclays | Underweight |
2018-05-17 | Ripresa | Piper Jaffray | Overweight |
2018-02-06 | Reiterato | Citigroup | Neutral |
2018-01-03 | Iniziato | Evercore ISI | Outperform |
2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Baxter to Host First-Quarter 2025 Financial Results Conference C - GuruFocus
Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors - The Joplin Globe
Latest Trends in Adhesion Barrier Market: 2024 to 2031 | Baxter - openPR.com
LSV Asset Management Has $159.96 Million Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Reaches New 1-Year LowShould You Sell? - MarketBeat
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care - TradingView
Jaffetilchin Investment Partners LLC Has $1.92 Million Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (BAX) Q3 2024 Earnings Call Transcript - Fortune
Baxter International (NYSE:BAX) Sets New 12-Month LowHere's Why - MarketBeat
Baxter International Inc. (NYSE:BAX) Position Raised by Russell Investments Group Ltd. - MarketBeat
Baxter International Enters Oversold Territory (BAX) - Nasdaq
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - PharmiWeb.com
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat - GuruFocus
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
Cullen Capital Management LLC Decreases Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Breakthrough: Baxter's Enhanced Hemopatch Eliminates Surgery Prep Time with Room-Temperature Storage - Stock Titan
Geode Capital Management LLC Buys 290,279 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Wound Care Market to Witness Remarkable Growth with 3M, Baxter, - openPR.com
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Baxter International Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Artificial Kidney Market to See Revolutionary Growth | Baxter - openPR.com
Baxter International Inc (BAX) Shares Down 3.27% on Apr 7 - GuruFocus
Citigroup Adjusts Baxter International Price Target to $35 From $37, Maintains Neutral Rating - MarketScreener
Baxter stock touches 52-week low at $28.22 amid market challenges - Investing.com Australia
Baxter stock touches 52-week low at $28.22 amid market challenges By Investing.com - Investing.com South Africa
Intravenous Solutions Market Is Booming Worldwide | Baxter - openPR.com
Allstate Corp Makes New $450,000 Investment in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Short Interest Update - MarketBeat
Healthcare: Policy Uncertainty Is Countered by Interest in Defensive Stocks - Morningstar
US hospitals strained by IV fluid supply limits after Helene hit production site - AOL.com
Evercore ISI Adjusts Baxter International Price Target to $45 From $44, Maintains Outperform Rating - MarketScreener
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Baxter CEO pay surged before his departure — along with the median employee’s wage - Medical Design & Outsourcing
Is Baxter International Inc. (BAX) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Insider Monkey
Baxter International (NYSE:BAX) investors are sitting on a loss of 55% if they invested five years ago - simplywall.st
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):